Last reviewed · How we verify
NCT07086209
Optimizing Hamstring Rehabilitation With Amino Acids
NA trial testing Branched-Chain Amino Acid Supplement in Seamless Return to Sports in 25 participants. Not yet recruiting.
19 October 2025
Quick facts
| Lead sponsor | Universidad de Zaragoza |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | single |
| Primary purpose | other |
| Enrollment | 25 |
| Start date | 19 September 2025 |
| Primary completion | 19 October 2025 |
| Estimated completion | 20 October 2025 |
Drugs / interventions tested
- Branched-Chain Amino Acid Supplement
- Therapeutic Exercise Program
Conditions studied
- Seamless Return to Sports — all drugs for Seamless Return to Sports →
Sponsor
Universidad de Zaragoza — full company profile →
Who can join
Under 60, any sex, with Seamless Return to Sports. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hamstring injuries are among the most prevalent and troublesome injuries in athletes, particularly those engaged in sports that require high-speed movements such as sprinting, kicking, and rapid changes in direction. The hamstring muscles, which include the biceps femoris, semitendinosus, and semimembranosus, are essential for powerful lower limb actions, and thus, any injury to these muscles can significantly impact an athlete's performance and recovery. These injuries often occur during eccentric muscle contractions, such as when the muscles lengthen rapidly under tension, as seen in running and sprinting. According to epidemiological studies, hamstring strains account for a substantial portion of sports-related injuries, with hamstring strains being the most commonly reported injury in disciplines such as football, soccer, rugby, and athletics. In professional football, for instance, hamstring injuries account for approximately 12% of all injuries and represent the most frequent muscle strain, underlining their significance in the context of athletic performance.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07086209
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Universidad de Zaragoza trials
Trials by the same sponsor.
- NCT07497217 — Change in ATOR Screening Test Scores Over 12 Weeks · NA · recruiting
- NCT07395830 — Effects of a Multisensory VR Experience on Stress and User Experience · NA · not yet recruiting
- NCT07398040 — Clinical Impact of an Anti-Inflammatory Diet in Anxiety and Depression With AI · NA · enrolling by invitation
- NCT07066696 — Mindfulness and Compassion Program for the Improvement of Emotional and Behavioral Problems, Academic Performance and Sc · NA · not yet recruiting
- NCT07098130 — Comparative Study of Two Ultrasound-guided Percutaneous Neuromodulation Protocols on Maximal Handgrip Strength. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07086209 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad de Zaragoza
- Last refreshed: 25 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07086209.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing